Biology of Sex Differences (Dec 2019)

Sex differences in clinical presentation of systemic lupus erythematosus

  • Jorge I. Ramírez Sepúlveda,
  • Karin Bolin,
  • Johannes Mofors,
  • Dag Leonard,
  • Elisabet Svenungsson,
  • Andreas Jönsen,
  • Christine Bengtsson,
  • the DISSECT consortium,
  • Gunnel Nordmark,
  • Solbritt Rantapää Dahlqvist,
  • Anders A. Bengtsson,
  • Lars Rönnblom,
  • Christopher Sjöwall,
  • Iva Gunnarsson,
  • Marie Wahren-Herlenius

DOI
https://doi.org/10.1186/s13293-019-0274-2
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 7

Abstract

Read online

Abstract Objective Systemic lupus erythematosus (SLE) predominantly affects women, but previous studies suggest that men with SLE present a more severe disease phenotype. In this study, we investigated a large and well-characterized patient group with the aim of identifying sex differences in disease manifestations, with a special focus on renal involvement. Methods We studied a Swedish multi-center SLE cohort including 1226 patients (1060 women and 166 men) with a mean follow-up time of 15.8 ± 13.4 years. Demographic data, disease manifestations including ACR criteria, serology and renal histopathology were investigated. Renal outcome and mortality were analyzed in subcohorts. Results Female SLE patients presented more often with malar rash (p < 0.0001), photosensitivity (p < 0.0001), oral ulcers (p = 0.01), and arthritis (p = 0.007). Male patients on the other hand presented more often with serositis (p = 0.0003), renal disorder (p < 0.0001), and immunologic disorder (p = 0.04) by the ACR definitions. With regard to renal involvement, women were diagnosed with nephritis at an earlier age (p = 0.006), while men with SLE had an overall higher risk for progression into end-stage renal disease (ESRD) with a hazard ratio (HR) of 5.1 (95% CI, 2.1–12.5). The mortality rate among men with SLE and nephritis compared with women was HR 1.7 (95% CI, 0.8–3.8). Conclusion SLE shows significant sex-specific features, whereby men are affected by a more severe disease with regard to both renal and extra-renal manifestations. Additionally, men are at a higher risk of developing ESRD which may require an increased awareness and monitoring in clinical practice.